NSPR - InspireMD, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
0.39
+0.00 (+1.04%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.39
Open0.39
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.39 - 0.44
52 Week Range0.30 - 4.39
Volume369,760
Avg. Volume381,440
Market Cap2.91M
Beta0.83
PE Ratio (TTM)-0.16
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • InspireMD Inc (NSPR): What Does It Mean For Your Portfolio?
    Simply Wall St.last month

    InspireMD Inc (NSPR): What Does It Mean For Your Portfolio?

    For InspireMD Inc’s (AMEX:NSPR) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. Generally, an investor shouldRead More...

  • InspireMD, Inc. :NSPR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube2 months ago

    InspireMD, Inc. :NSPR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis InspireMD, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of InspireMD, Inc. – Edwards Lifesciences Corporation, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories and Medtronic plc (EW-US, SYK-US, BSX-US, JNJ-US, ABT-US and MDT-US) that have also ... Read more (Read more...)

  • InspireMD, Inc. :NSPR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
    Capital Cube5 months ago

    InspireMD, Inc. :NSPR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017

    Categories: Yahoo FinanceGet free summary analysis InspireMD, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of InspireMD, Inc. – Stryker Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories and Spectranetics Corporation (SYK-US, EW-US, BSX-US, JNJ-US, ABT-US and SPNC-US) that have also ... Read more (Read more...)

  • InspireMD, Inc. :NSPR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube7 months ago

    InspireMD, Inc. :NSPR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis InspireMD, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of InspireMD, Inc. – Stryker Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Spectranetics Corporation and Medtronic plc (SYK-US, EW-US, BSX-US, JNJ-US, ABT-US, SPNC-US and MDT-US) ... Read more (Read more...)

  • InspireMD, Inc. :NSPR-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
    Capital Cube7 months ago

    InspireMD, Inc. :NSPR-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017

    Categories: Yahoo Finance Get free summary analysis InspireMD, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of InspireMD, Inc. – Stryker Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Spectranetics Corporation and Medtronic plc (SYK-US, EW-US, BSX-US, JNJ-US, ABT-US, SPNC-US and MDT-US) ... Read more (Read more...)

  • 24/7 Wall St.last year

    Why InspireMD More Than Doubled

    Shares of InspireMD more than doubled in Tuesday’s session after the company announced followup data from its Paradigm-101 trial of the CGuard Embolic Prevention System.